UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 12.270

Sortiert nach

Costs increase with AF burden in older patients with implantable devices

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.4-4

2021

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab + EP not cost effective vs EP as first-line treatment for SCLC in the USA

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.17-17

2021

Link zum Volltext

Verfügbarkeit prüfen

MRI plus targeted biopsy optimal choice for early detection of prostate cancer in Sweden

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.15-15

2021

Link zum Volltext

Verfügbarkeit prüfen

TB screening + treatment of young asylum seekers arriving in Germany may be cost effective

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.31-31

2021

Link zum Volltext

Verfügbarkeit prüfen

Olaparib cost effective for in BRCA-mutated advanced ovarian carcinoma in Spain

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.16-16

2021

Link zum Volltext

Verfügbarkeit prüfen

Systematic review: population-based testing for hepatitis C may be a cost-effective strategy

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.28-28

2021

Link zum Volltext

Verfügbarkeit prüfen

Radiation therapy cost-effective option for low-risk localised prostate cancer in Australia

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.19-19

2021

Link zum Volltext

Verfügbarkeit prüfen

A Fond Farewell from PharmacoEconomics & Outcomes News

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.1-1

2021

Link zum Volltext

Verfügbarkeit prüfen

Semaglutide + metformin not cost effective vs empagliflozin + metformin for T2DM in Denmark

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.23-23

2021

Link zum Volltext

Verfügbarkeit prüfen

Barriers to prescription drug access within US commercial insurance

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.33-33

2021

Link zum Volltext

Verfügbarkeit prüfen

Reimbursement and pricing for innovative drugs in France: identifying criteria to inform decision-making

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.20-20

2021

Link zum Volltext

Verfügbarkeit prüfen

UK's NICE updated guideline recommends progesterone to prevent early miscarriage

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.37-37

2021

Link zum Volltext

Verfügbarkeit prüfen

Lifelong immunoglobulin replacement therapy for agammaglobulinaemia too costly in the USA

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.12-12

2021

Link zum Volltext

Verfügbarkeit prüfen

Domiciliary ventilation cost effective after hospitalisation for COPD

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.7-7

2021

Link zum Volltext

Verfügbarkeit prüfen

NICE recommends osimertinib for NSCLC within Cancer Drugs Fund

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.36-36

2021

Link zum Volltext

Verfügbarkeit prüfen

Influenza vaccine cost effective in pregnant and older adults in Laos

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.11-11

2021

Link zum Volltext

Verfügbarkeit prüfen

Single-use clean intermittent catheters cost effective for managing neurogenic LUTD in Canada

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.25-25

2021

Link zum Volltext

Verfügbarkeit prüfen

DTG-containing HIV treatments regimens appear to be cost effective in South Aftrica

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.8-8

2021

Link zum Volltext

Verfügbarkeit prüfen

Supplementary DECT imaging cost effective for diagnosing occult hip fractures in Singapore

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.26-26

2021

Link zum Volltext

Verfügbarkeit prüfen

Additional MRI more effective for initial staging in pancreatic cancer than standard imaging and less costly

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.3-3

2021

Link zum Volltext

Verfügbarkeit prüfen

Population genomic screening of all Australian adults for FH could be cost effective

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.18-18

2021

Link zum Volltext

Verfügbarkeit prüfen

Most cost effective strategy for para-aortic lymph node detection in LACC patients in Thailand?

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.14-14

2021

Link zum Volltext

Verfügbarkeit prüfen

ICER issues final evidence report for mavacamten for hypertrophic cardiomyopathy

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.34-34

2021

Link zum Volltext

Verfügbarkeit prüfen

Systematic review: inconsistent methods for calculating informal care costs for dementia

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.27-27

2021

Link zum Volltext

Verfügbarkeit prüfen

Direct healthcare costs of patients with dyshidrotic eczema in the USA?

PharmacoEconomics & outcomes news, 2021-12, Vol.893 (1), p.6-6

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 12.270

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SeriePharmacoeconomics & Outcomes News

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1)
Mit Volltextzugriff
(12.270)

Publikationsform

Artikel
(12.270)

Sprache

Englisch
(12.270)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Public Health
(12.270)
Health Economics
(12.268)
Medicine
(12.268)
Medicine & Public Health
(12.268)
Pharmacoeconomics And Health Outcomes
(12.268)
Quality Of Life Research
(12.268)
Clinical Study
(7.557)
News Item
(2.314)
Media Release
(1.272)
Non-Clinical Study
(332)
Analysis
(294)
Economic Aspects
(280)
Medical Care, Cost Of
(260)
Care And Treatment
(227)
Meeting Report
(221)
Health Aspects
(199)
Comment
(190)
Drug Therapy
(143)
Review
(126)
Guideline
(112)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Pharmacoeconomics
(1)

Menü

Weitere Dienste

Einstellungen

Costs increase with AF burden in older patients with implantable devices

Pembrolizumab + EP not cost effective vs EP as first-line treatment for SCLC in the USA

MRI plus targeted biopsy optimal choice for early detection of prostate cancer in Sweden

TB screening + treatment of young asylum seekers arriving in Germany may be cost effective

Olaparib cost effective for in BRCA-mutated advanced ovarian carcinoma in Spain

Systematic review: population-based testing for hepatitis C may be a cost-effective strategy

Radiation therapy cost-effective option for low-risk localised prostate cancer in Australia

A Fond Farewell from PharmacoEconomics & Outcomes News

Semaglutide + metformin not cost effective vs empagliflozin + metformin for T2DM in Denmark

Barriers to prescription drug access within US commercial insurance

Reimbursement and pricing for innovative drugs in France: identifying criteria to inform decision-making

UK's NICE updated guideline recommends progesterone to prevent early miscarriage

Lifelong immunoglobulin replacement therapy for agammaglobulinaemia too costly in the USA

Domiciliary ventilation cost effective after hospitalisation for COPD

NICE recommends osimertinib for NSCLC within Cancer Drugs Fund

Influenza vaccine cost effective in pregnant and older adults in Laos

Single-use clean intermittent catheters cost effective for managing neurogenic LUTD in Canada

DTG-containing HIV treatments regimens appear to be cost effective in South Aftrica

Supplementary DECT imaging cost effective for diagnosing occult hip fractures in Singapore

Additional MRI more effective for initial staging in pancreatic cancer than standard imaging and less costly

Population genomic screening of all Australian adults for FH could be cost effective

Most cost effective strategy for para-aortic lymph node detection in LACC patients in Thailand?

ICER issues final evidence report for mavacamten for hypertrophic cardiomyopathy

Systematic review: inconsistent methods for calculating informal care costs for dementia

Direct healthcare costs of patients with dyshidrotic eczema in the USA?

Aktive Filter

Suchergebnisse filtern